Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH antagonist protocols in DUOSTIM with embryo accumulation for PGT-A
2023-508769-33-00Phase 4Authorised
- Sponsor
- Ginefiv
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of medroxyprogesterone acetate and ganirelix in female infertility (2 arms), sponsored by Ginefiv. Primary endpoint: number of euploid embryos. Planned start Mar 2024; status: authorised.
02
Drugs
medroxyprogesterone acetateganirelix
03
Conditions
female infertility
Beyond the preview
Go deeper on 2023-508769-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508769-33-00.